Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease

被引:0
|
作者
Alcalay, Roy N. [1 ]
Mejia-Santana, Helen [1 ]
Tang, Ming Xin [1 ,3 ]
Rosado, Llency [1 ]
Verbitsky, Miguel [3 ]
Kisselev, Sergey [3 ]
Ross, Barbara M. [3 ]
Louis, Elan D. [1 ,3 ,4 ,6 ]
Comella, Cynthia L. [12 ]
Colcher, Amy [16 ]
Jennings, Danna [14 ]
Nance, Martha A. [17 ]
Bressman, Susan [8 ,9 ]
Scott, William K. [18 ]
Tanner, Caroline [21 ]
Mickel, Susan F. [20 ]
Andrews, Howard F. [10 ]
Waters, Cheryl H. [1 ]
Fahn, Stanley [1 ]
Cote, Lucien J. [4 ]
Frucht, Steven J. [1 ]
Ford, Blair [1 ]
Rezak, Michael [11 ,13 ]
Novak, Kevin [11 ,13 ]
Friedman, Joseph H. [22 ,23 ]
Pfeiffer, Ronald [24 ]
Marsh, Laura [25 ,26 ]
Hiner, Bradley [19 ]
Siderowf, Andrew [15 ]
Caccappolo, Elise [3 ]
Ottman, Ruth [4 ,6 ]
Clark, Lorraine N. [2 ,3 ,5 ]
Marder, Karen S. [1 ,3 ,4 ,7 ]
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
[3] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[4] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA
[5] Columbia Univ, Coll Phys & Surg, Ctr Human Genet, New York, NY 10032 USA
[6] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[7] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA
[8] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[9] Albert Einstein Coll Med, Beth Israel Med Ctr, Alan & Barbara Mirken Dept Neurol, Bronx, NY 10467 USA
[10] Albert Einstein Coll Med, Data Coordinating Ctr, New York State Psychiat Inst, Bronx, NY 10467 USA
[11] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA
[12] Rush Univ, Dept Neurol, Movement Disorder Sect, Chicago, IL 60612 USA
[13] NorthShore Univ HealthSyst, Dept Neurol, Evanston, IL USA
[14] Inst Neurodegenerat Disorders, New Haven, CT USA
[15] Univ Penn Hlth Syst, Dept Neurol, Philadelphia, PA USA
[16] Univ Penn Hlth Syst, Parkinsons Dis & Movement Disorders Ctr, Penn Hosp, Philadelphia, PA USA
[17] Park Nicollet Clin, Struthers Parkinsons Ctr, Golden Valley, MN USA
[18] Univ Miami, Miller Sch Med, Dept Human Genet, Miami Inst Human Genom,Dr John T Macdonald Fdn, Miami, FL 33136 USA
[19] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[20] Marshfield Clin Fdn Med Res & Educ, Dept Neurol, Marshfield, WI USA
[21] Parkinsons Inst, Sunnyvale, CA USA
[22] Parkinsons Dis & Movement Disorders Ctr NeuroHlth, Warwick, England
[23] Brown Univ, Warren Alpert Sch Med, Dept Clin Neurosci, Providence, RI 02912 USA
[24] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Neurol, Memphis, TN 38163 USA
[25] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci & Neurol & Neurol Sci, Baltimore, MD USA
[26] Johns Hopkins Univ, Morris K Udall Parkinsons Dis Res Ctr Excellence, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
TREMOR-DOMINANT PARKINSONISM; LEWY BODIES; MUTATION; DEMENTIA; GENE; SUBTYPE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the motor phenotype of LRRK2 G2019S mutation carriers. LRRK2 mutation carriers were previously reported to manifest the tremor dominant motor phenotype, which has been associated with slower motor progression and less cognitive impairment compared with the postural instability and gait difficulty (PIGD) phenotype. Design: Cross-sectional observational study. Setting: Thirteen movement disorders centers. Participants: Nine hundred twenty-five early-onset Parkinson disease cases defined as age at onset younger than 51 years. Main Outcome Measures: LRRK2 mutation status and Parkinson disease motor phenotype: tremor dominant or PIGD. Demographic information, family history of Parkinson disease, and the Unified Parkinson's Disease Rating Scale score were collected on all participants. DNA samples were genotyped for LRRK2 mutations (G2019S, I2020T, R1441C, and Y1699C). Logistic regression was used to examine associations of G2019S mutation status with motor phenotype adjusting for disease duration, Ashkenazi Jewish ancestry, levodopa dose, and family history of Parkinson disease. Results: Thirty-four cases (3.7%) (14 previously reported) were G2019S carriers. No other mutations were found. Carriers were more likely to be Ashkenazi Jewish (55.9% vs 11.9%; P < .001) but did not significantly differ in any other demographic or disease characteristics. Carriers had a lower tremor score (P=.03) and were more likely to have a PIGD phenotype (92.3% vs 58.9%; P=.003). The association of the G2019S mutation with PIGD phenotype remained after controlling for disease duration and Ashkenazi Jewish ancestry (odds ratio, 17.7; P<.001). Conclusion: Early-onset Parkinson disease G2019S LRRK2 carriers are more likely to manifest the PIGD phenotype, which may have implications for disease course.
引用
收藏
页码:1517 / 1522
页数:6
相关论文
共 50 条
  • [31] Remote assessment of prodromal Parkinson's disease in a LRRK2 G2019S cohort
    Soto, J.
    Jensen-Roberts, S.
    Meyers, T.
    Pawlik, M.
    Moore, J.
    Sarkar, A.
    Wilson, R.
    Auinger, P.
    Dorsey, E.
    Valdovinos, B.
    Amodeo, K.
    Sharma, S.
    Holloway, R.
    Rowbotham, H.
    Chanoff, E.
    Cannon, P.
    Alcalay, R.
    Schneider, R.
    MOVEMENT DISORDERS, 2021, 36 : S323 - S324
  • [32] LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
    Infante, J
    Rodríguez, E
    Combarros, O
    Mateo, I
    Fontalba, A
    Pascual, J
    Oterino, A
    Polo, JM
    Leno, C
    Berciano, J
    NEUROSCIENCE LETTERS, 2006, 395 (03) : 224 - 226
  • [33] The LRRK2 G2019S Mutation Predisposes Parkinson's Disease Patients to Cancer
    Inzelberg, Rivka
    Cohen, Oren S.
    Aharon-Peretz, Judith
    Schlesinger, Ilana
    Yaakov, Zichron
    Gershoni-Baruch, Ruth
    Djaldetti, Ruth
    Nitzan, Zeev
    Ephraty, Lilach
    Tunkel, Olga
    Kozlova, Evgenya
    Inzelberg, Lilah
    Schechtman, Edna
    Kaplan, Natali
    Friedman, Eitan
    Hassin-Baer, Sharon
    NEUROLOGY, 2011, 76 (09) : A17 - A17
  • [34] The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews
    Thaler, Avner
    Ash, Elissa
    Gan-Or, Ziv
    Orr-Urtreger, Avi
    Giladi, Nir
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (11) : 1473 - 1482
  • [35] Clinical evaluation of asymptomatic G2019S LRRK2 mutation carriers and assessment of factors influencing LRRK2 related Parkinson's disease expression (the ASAP LRRK2 study)
    Gaig, C.
    Tolosa, E.
    Ezguerra, M.
    Rojo, A.
    Aguilar, M.
    Hernandez, J.
    Miquel, F.
    Calopa, M.
    Pastor, P.
    MOVEMENT DISORDERS, 2007, 22 : S173 - S173
  • [36] The LRRK2 G2019S mutation predisposes Parkinson's disease patients to cancer
    Inzelberg, R.
    Cohen, O.
    Aharon-Peretz, J.
    Schlesinger, I.
    Gershoni-Baruch, R.
    Djaldetti, R.
    Nitsan, Z.
    Ephraty, L.
    Tunkel, O.
    Kozlova, E.
    Inzelberg, L.
    Kaplan, N.
    Schechtman, E.
    Friedman, E.
    Hassin-Baer, S.
    MOVEMENT DISORDERS, 2011, 26 : S310 - S310
  • [37] The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease
    Cho, J.
    Kim, H.
    Park, S.
    Jeon, B.
    MOVEMENT DISORDERS, 2006, 21 : S402 - S402
  • [38] Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson's disease
    Chien, Hsin Fen
    Figueiredo, Tamires Rocha
    Hollaender, Marianna Almeida
    Tofoli, Fabiano
    Takada, Leonel Tadao
    Pereira, Lygia do Veiga
    Barbosa, Egberto Reis
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2014, 72 (05) : 356 - 359
  • [39] LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
    Lesage, S
    Dürr, A
    Tazir, M
    Lohmann, E
    Leutenegger, AL
    Janin, S
    Pollak, P
    Brice, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (04): : 422 - 423
  • [40] LRRK2 G2019S Mutation in an Argentinean Cohort of Patients with Parkinson's Disease
    Gatto, Emilia M.
    Converso, Daniela P.
    Marti-Masso, Jose F.
    Sebastian, San
    Ruiz, Coro Paisan
    Persi, Gabriel
    Etcheverry, Jose L.
    Parisi, Virginia
    Leiguarda, Fernando
    Carreras, Maria C.
    Poderoso, Juan J.
    NEUROLOGY, 2010, 74 (09) : A253 - A253